{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:54:15Z","timestamp":1793656455276,"version":"4.5.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930108"],"award-info":[{"award-number":["81930108"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170373"],"award-info":[{"award-number":["82170373"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Key Scientific Project"},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY22H070004"],"award-info":[{"award-number":["LY22H070004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Obesity increases the risk for cardiovascular diseases and induces cardiomyopathy. Chronic inflammation plays a significant role in obesity-induced cardiomyopathy and may provide new therapeutic targets for this disease. Doublecortin-like kinase 1 (DCLK1) is an important target for cancer therapy and the role of DCLK1 in obesity and cardiovascular diseases is unclear. Herein, we showed that DCLK1 was overexpressed in the cardiac tissue of obese mice and investigated the role of DCLK1 in obesity-induced cardiomyopathy. We generated DCLK1-deleted mice and showed that macrophage-specific DCLK1 knockout, rather than cardiomyocyte-specific DCLK1 knockout, prevented high-fat diet (HFD)-induced heart dysfunction, cardiac hypertrophy, and fibrosis. RNA sequencing analysis showed that DCLK1 deficiency exerted cardioprotective effects by suppressing RIP2\/TAK1 activation and inflammatory responses in macrophages. Upon HFD\/palmitate (PA) challenge, macrophage DCLK1 mediates RIP2\/TAK1 phosphorylation and subsequent inflammatory cytokine release, which further promotes hypertrophy in cardiomyocytes and fibrogenesis in fibroblasts. Finally, a pharmacological inhibitor of DCLK1 significantly protects hearts in HFD-fed mice. Our study demonstrates a novel role and a pro-inflammatory mechanism of macrophage DCLK1 in obesity-induced cardiomyopathy and identifies DCLK1 as a new therapeutic target for the treatment of this disease.<\/jats:p>","DOI":"10.1038\/s41419-023-05960-4","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T06:04:31Z","timestamp":1689228271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2\/TAK1 signaling pathway"],"prefix":"10.1038","volume":"14","author":[{"given":"Bin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiming","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxiu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-0092","authenticated-orcid":false,"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8278-849X","authenticated-orcid":false,"given":"Guang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"5960_CR1","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41569-020-00465-5","volume":"18","author":"A Ng","year":"2021","unstructured":"Ng A, Delgado V, Borlaug B, Bax J. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol. 2021;18:291\u2013304.","journal-title":"Nat Rev Cardiol"},{"key":"5960_CR2","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/s41571-022-00672-8","volume":"19","author":"T Ugai","year":"2022","unstructured":"Ugai T, Sasamoto N, Lee HY, Ando M, Song M, Tamimi RM, et al. Is early-onset cancer an emerging global epidemic? Current evidence and future implications. Nat Rev Clin Oncol. 2022;19:656\u201373.","journal-title":"Nat Rev Clin Oncol"},{"key":"5960_CR3","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1016\/j.cell.2022.08.005","volume":"185","author":"Y Kawano","year":"2022","unstructured":"Kawano Y, Edwards M, Huang Y, Bilate AM, Araujo LP, Tanoue T, et al. Microbiota imbalance induced by dietary sugar disrupts immune-mediated protection from metabolic syndrome. Cell. 2022;185:3501\u201319.e20.","journal-title":"Cell"},{"key":"5960_CR4","doi-asserted-by":"publisher","first-page":"154892","DOI":"10.1016\/j.metabol.2021.154892","volume":"125","author":"L Mastrototaro","year":"2021","unstructured":"Mastrototaro L, Roden M. Insulin resistance and insulin sensitizing agents. Metabolism. 2021;125:154892.","journal-title":"Metabolism"},{"key":"5960_CR5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1161\/CIRCRESAHA.121.318159","volume":"128","author":"WJ Paulus","year":"2021","unstructured":"Paulus WJ, Zile MR. From systemic inflammation to myocardial fibrosis: the heart failure with preserved ejection fraction paradigm revisited. Circ Res. 2021;128:1451\u201367.","journal-title":"Circ Res"},{"key":"5960_CR6","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41569-022-00718-5","volume":"19","author":"I Akoumianakis","year":"2022","unstructured":"Akoumianakis I, Polkinghorne M, Antoniades C. Non-canonical WNT signalling in cardiovascular disease: mechanisms and therapeutic implications. Nat Rev Cardiol. 2022;19:783\u201397.","journal-title":"Nat Rev Cardiol"},{"key":"5960_CR7","first-page":"868","volume":"43","author":"JJ Rayner","year":"2021","unstructured":"Rayner JJ, Peterzan MA, Clarke WT, Rodgers CT, Neubauer S, Rider OJ. Obesity modifies the energetic phenotype of dilated cardiomyopathy. Eur Heart J. 2021;43:868\u201377.","journal-title":"Eur Heart J"},{"key":"5960_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.metabol.2018.10.011","volume":"92","author":"C Koliaki","year":"2019","unstructured":"Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98\u2013107.","journal-title":"Metabolism"},{"key":"5960_CR9","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1152\/physrev.00030.2020","volume":"101","author":"J Ren","year":"2021","unstructured":"Ren J, Wu NN, Wang S, Sowers JR, Zhang Y. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications. Physiol Rev. 2021;101:1745\u2013807.","journal-title":"Physiol Rev"},{"key":"5960_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1093\/cvr\/cvx012","volume":"113","author":"K Nishida","year":"2017","unstructured":"Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017;113:389\u201398.","journal-title":"Cardiovasc Res"},{"key":"5960_CR11","doi-asserted-by":"publisher","first-page":"e139576","DOI":"10.1172\/JCI139576","volume":"131","author":"M DeBerge","year":"2021","unstructured":"DeBerge M, Glinton K, Subramanian M, Wilsbacher LD, Rothlin CV, Tabas I, et al. Macrophage AXL receptor tyrosine kinase inflames the heart after reperfused myocardial infarction. J Clin Invest. 2021;131:e139576.","journal-title":"J Clin Invest"},{"key":"5960_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","volume":"126","author":"AJ Mouton","year":"2020","unstructured":"Mouton AJ, Li X, Hall ME, Hall JE. Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation. Circ Res. 2020;126:789\u2013806.","journal-title":"Circ Res"},{"key":"5960_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407.","journal-title":"Nat Rev Cardiol"},{"key":"5960_CR14","doi-asserted-by":"publisher","first-page":"154194","DOI":"10.1016\/j.metabol.2020.154194","volume":"106","author":"J Skurski","year":"2020","unstructured":"Skurski J, Penniman CM, Geesala R, Dixit G, Pulipati P, Bhardwaj G, et al. Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation. Metabolism. 2020;106:154194.","journal-title":"Metabolism"},{"key":"5960_CR15","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.120.053365","volume":"144","author":"M Korf-Klingebiel","year":"2021","unstructured":"Korf-Klingebiel M, Reboll MR, Polten F, Weber N, J\u00e4ckle F, Wu X, et al. Myeloid-derived growth factor protects against pressure overload-induced heart failure by preserving sarco\/endoplasmic reticulum Ca(2+)-ATPase expression in cardiomyocytes. Circulation. 2021;144:1227\u201340.","journal-title":"Circulation"},{"key":"5960_CR16","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1084\/jem.20111790","volume":"210","author":"W Zou","year":"2013","unstructured":"Zou W, Greenblatt MB, Brady N, Lotinun S, Zhai B, de Rivera H, et al. The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2. J Exp Med. 2013;210:1793\u2013806.","journal-title":"J Exp Med"},{"key":"5960_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2016.11.005","volume":"31","author":"Y Hayakawa","year":"2017","unstructured":"Hayakawa Y, Sakitani K, Konishi M, Asfaha S, Niikura R, Tomita H, et al. Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling. Cancer Cell. 2017;31:21\u201334.","journal-title":"Cancer Cell"},{"key":"5960_CR18","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2019.08.018","volume":"157","author":"P Dandawate","year":"2019","unstructured":"Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, et al. The histone demethylase KDM3A, increased in human pancreatic tumors, regulates expression of DCLK1 and promotes tumorigenesis in mice. Gastroenterology. 2019;157:1646\u201359.e11.","journal-title":"Gastroenterology"},{"key":"5960_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-103","volume":"13","author":"N Weygant","year":"2014","unstructured":"Weygant N, Qu D, Berry WL, May R, Chandrakesan P, Owen DB, et al. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Mol Cancer. 2014;13:103.","journal-title":"Mol Cancer"},{"key":"5960_CR20","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41418-018-0237-x","volume":"26","author":"J Yi","year":"2019","unstructured":"Yi J, Bergstrom K, Fu J, Shan X, McDaniel JM, McGee S, et al. Dclk1 in tuft cells promotes inflammation-driven epithelial restitution and mitigates chronic colitis. Cell Death Differ. 2019;26:1656\u201369.","journal-title":"Cell Death Differ"},{"key":"5960_CR21","doi-asserted-by":"publisher","first-page":"20327","DOI":"10.18632\/oncotarget.3972","volume":"6","author":"N Ali","year":"2015","unstructured":"Ali N, Chandrakesan P, Nguyen CB, Husain S, Gillaspy AF, Huycke M, et al. Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases. Oncotarget. 2015;6:20327\u201344.","journal-title":"Oncotarget"},{"key":"5960_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15978-3","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Luo W, Han J, Khan ZA, Fang Q, Jin Y, et al. MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy. Nat Commun. 2020;11:2148.","journal-title":"Nat Commun"},{"key":"5960_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-021-00542-2","volume":"6","author":"D Wang","year":"2021","unstructured":"Wang D, Yin Y, Wang S, Zhao T, Gong F, Zhao Y, et al. FGF1(\u0394HBS) prevents diabetic cardiomyopathy by maintaining mitochondrial homeostasis and reducing oxidative stress via AMPK\/Nur77 suppression. Signal Transduct Target Ther. 2021;6:133.","journal-title":"Signal Transduct Target Ther"},{"key":"5960_CR24","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.2337\/db13-1577","volume":"63","author":"Y Pan","year":"2014","unstructured":"Pan Y, Wang Y, Zhao Y, Peng K, Li W, Wang Y, et al. Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes. 2014;63:3497\u2013511.","journal-title":"Diabetes"},{"key":"5960_CR25","doi-asserted-by":"publisher","first-page":"975","DOI":"10.2147\/DDDT.S195412","volume":"13","author":"B Ye","year":"2019","unstructured":"Ye B, Chen X, Dai S, Han J, Liang X, Lin S, et al. Emodin alleviates myocardial ischemia\/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes. Drug Des Devel Ther. 2019;13:975\u201390.","journal-title":"Drug Des Devel Ther"},{"key":"5960_CR26","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41569-018-0086-9","volume":"15","author":"SM Meilhac","year":"2018","unstructured":"Meilhac SM, Buckingham ME. The deployment of cell lineages that form the mammalian heart. Nat Rev Cardiol. 2018;15:705\u201324.","journal-title":"Nat Rev Cardiol"},{"key":"5960_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41589-020-0506-0","volume":"16","author":"FM Ferguson","year":"2020","unstructured":"Ferguson FM, Nabet B, Raghavan S, Liu Y, Leggett AL, Kuljanin M, et al. Discovery of a selective inhibitor of doublecortin like kinase 1. Nat Chem Biol. 2020;16:635\u201343.","journal-title":"Nat Chem Biol"},{"key":"5960_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","volume":"670","author":"JM Platnich","year":"2019","unstructured":"Platnich JM, Muruve DA. NOD-like receptors and inflammasomes: a review of their canonical and non-canonical signaling pathways. Arch Biochem Biophys. 2019;670:4\u201314.","journal-title":"Arch Biochem Biophys"},{"key":"5960_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Inserra MC, et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015;21:248\u201355.","journal-title":"Nat Med"},{"key":"5960_CR30","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41401-020-00603-2","volume":"42","author":"L Chen","year":"2021","unstructured":"Chen L, Cao SQ, Lin ZM, He SJ, Zuo JP. NOD-like receptors in autoimmune diseases. Acta Pharm Sin. 2021;42:1742\u201356.","journal-title":"Acta Pharm Sin"},{"key":"5960_CR31","doi-asserted-by":"publisher","first-page":"112417","DOI":"10.1016\/j.ejmech.2020.112417","volume":"200","author":"C Suebsuwong","year":"2020","unstructured":"Suebsuwong C, Dai B, Pinkas DM, Duddupudi AL, Li L, Bufton JC, et al. Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold. Eur J Med Chem. 2020;200:112417.","journal-title":"Eur J Med Chem"},{"key":"5960_CR32","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1161\/CIRCULATIONAHA.118.034621","volume":"138","author":"T Suetomi","year":"2018","unstructured":"Suetomi T, Willeford A, Brand CS, Cho Y, Ross RS, Miyamoto S, et al. Inflammation and NLRP3 inflammasome activation initiated in response to pressure overload by Ca(2+)\/calmodulin-dependent protein kinase II \u03b4 signaling in cardiomyocytes are essential for adverse cardiac remodeling. Circulation. 2018;138:2530\u201344.","journal-title":"Circulation"},{"key":"5960_CR33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2022.01.014","volume":"530","author":"D Nomoto","year":"2022","unstructured":"Nomoto D, Baba Y, Liu Y, Tsutsuki H, Okadome K, Harada K, et al. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1\/RIPK2\/NF-\u03baB pathway. Cancer Lett. 2022;530:59\u201367.","journal-title":"Cancer Lett"},{"key":"5960_CR34","doi-asserted-by":"publisher","first-page":"106392","DOI":"10.1016\/j.intimp.2020.106392","volume":"83","author":"Q Gao","year":"2020","unstructured":"Gao Q, Wang Y, Ma N, Dai H, Roy AC, Chang G, et al. Sodium valproate attenuates the iE-DAP induced inflammatory response by inhibiting the NOD1-NF-\u03baB pathway and histone modifications in bovine mammary epithelial cells. Int Immunopharmacol. 2020;83:106392.","journal-title":"Int Immunopharmacol"},{"key":"5960_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2017.09.034","volume":"1678","author":"H Yu","year":"2018","unstructured":"Yu H, Wu M, Lu G, Cao T, Chen N, Zhang Y, et al. Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL\/6 mouse model of cuprizone-induced demyelination. Brain Res. 2018;1678:75\u201384.","journal-title":"Brain Res"},{"key":"5960_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-0904-1","volume":"566","author":"K Vriens","year":"2019","unstructured":"Vriens K, Christen S, Parik S, Broekaert D, Yoshinaga K, Talebi A, et al. Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity. Nature 2019;566:403\u20136.","journal-title":"Nature"},{"key":"5960_CR37","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1161\/CIRCULATIONAHA.119.043053","volume":"141","author":"Z Ren","year":"2020","unstructured":"Ren Z, Yu P, Li D, Li Z, Liao Y, Wang Y, et al. Single-cell reconstruction of progression trajectory reveals intervention principles in pathological cardiac hypertrophy. Circulation 2020;141:1704\u201319.","journal-title":"Circulation"},{"key":"5960_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41420-021-00526-9","volume":"7","author":"BC Roy","year":"2021","unstructured":"Roy BC, Ahmed I, Stubbs J, Zhang J, Attard T, Septer S, et al. DCLK1 isoforms and aberrant Notch signaling in the regulation of human and murine colitis. Cell Death Discov. 2021;7:169.","journal-title":"Cell Death Discov"},{"key":"5960_CR39","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1523\/JNEUROSCI.1076-19.2019","volume":"40","author":"GE V\u00e1zquez-V\u00e9lez","year":"2020","unstructured":"V\u00e1zquez-V\u00e9lez GE, Gonzales KA, Revelli JP, Adamski CJ, Alavi Naini F, Baji\u0107 A, et al. Doublecortin-like kinase 1 regulates \u03b1-synuclein levels and toxicity. J Neurosci. 2020;40:459\u201377.","journal-title":"J Neurosci"},{"key":"5960_CR40","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1158\/0008-5472.CAN-14-0471","volume":"74","author":"T Sakurai","year":"2014","unstructured":"Sakurai T, Kashida H, Watanabe T, Hagiwara S, Mizushima T, Iijima H, et al. Stress response protein cirp links inflammation and tumorigenesis in colitis-associated cancer. Cancer Res. 2014;74:6119\u201328.","journal-title":"Cancer Res"},{"key":"5960_CR41","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jhep.2021.12.012","volume":"76","author":"O Govaere","year":"2022","unstructured":"Govaere O, Petersen SK, Martinez-Lopez N, Wouters J, Van Haele M, Mancina RM, et al. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. J Hepatol. 2022;76:1001\u201312.","journal-title":"J Hepatol"},{"key":"5960_CR42","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell. 2021;184:2537\u201364.","journal-title":"Cell"},{"key":"5960_CR43","doi-asserted-by":"publisher","first-page":"154404","DOI":"10.1016\/j.metabol.2020.154404","volume":"114","author":"X Wang","year":"2021","unstructured":"Wang X, Chen S, He J, Chen W, Ding Y, Huang J, et al. Histone methyltransferases G9a mediated lipid-induced M1 macrophage polarization through negatively regulating CD36. Metabolism. 2021;114:154404.","journal-title":"Metabolism"},{"key":"5960_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.metabol.2018.01.013","volume":"83","author":"XQ Xiong","year":"2018","unstructured":"Xiong XQ, Geng Z, Zhou B, Zhang F, Han Y, Zhou YB, et al. FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism. 2018;83:31\u201341.","journal-title":"Metabolism"},{"key":"5960_CR45","doi-asserted-by":"publisher","first-page":"154393","DOI":"10.1016\/j.metabol.2020.154393","volume":"113","author":"A Hafiane","year":"2020","unstructured":"Hafiane A, Daskalopoulou SS. Adiponectin\u2019s mechanisms in high-density lipoprotein biogenesis and cholesterol efflux. Metabolism. 2020;113:154393.","journal-title":"Metabolism"},{"key":"5960_CR46","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1161\/CIRCULATIONAHA.119.041213","volume":"142","author":"HB Lin","year":"2020","unstructured":"Lin HB, Naito K, Oh Y, Farber G, Kanaan G, Valaperti A, et al. Innate immune Nod1\/RIP2 signaling is essential for cardiac hypertrophy but requires mitochondrial antiviral signaling protein for signal transductions and energy balance. Circulation. 2020;142:2240\u201358.","journal-title":"Circulation"},{"key":"5960_CR47","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1159\/000356618","volume":"32","author":"X Li","year":"2013","unstructured":"Li X, Li F, Chu Y, Wang X, Zhang H, Hu Y, et al. NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice. Cell Physiol Biochem. 2013;32:1857\u201366.","journal-title":"Cell Physiol Biochem"},{"key":"5960_CR48","doi-asserted-by":"publisher","first-page":"154238","DOI":"10.1016\/j.phymed.2022.154238","volume":"103","author":"C Dai","year":"2022","unstructured":"Dai C, Luo W, Chen Y, Shen S, Wang Z, Chen R, et al. Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation. Phytomedicine. 2022;103:154238.","journal-title":"Phytomedicine"},{"key":"5960_CR49","first-page":"e21761","volume":"35","author":"I Amador-Mart\u00ednez","year":"2021","unstructured":"Amador-Mart\u00ednez I, Garc\u00eda-Ballhaus J, Buelna-Chontal M, Cort\u00e9s-Gonz\u00e1lez C, Mass\u00f3 F, Jaisser F, et al. Early inflammatory changes and CC chemokine ligand-8 upregulation in the heart contribute to uremic cardiomyopathy. Faseb B. 2021;35:e21761.","journal-title":"Faseb B"},{"key":"5960_CR50","doi-asserted-by":"publisher","first-page":"650213","DOI":"10.3389\/fgene.2021.650213","volume":"12","author":"D Wang","year":"2021","unstructured":"Wang D, Xiong T, Yu W, Liu B, Wang J, Xiao K, et al. Predicting the key genes involved in aortic valve calcification through integrated bioinformatics analysis. Front Genet. 2021;12:650213.","journal-title":"Front Genet"},{"key":"5960_CR51","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3892\/ijo.2022.5427","volume":"61","author":"Q Lu","year":"2022","unstructured":"Lu Q, Feng H, Chen H, Weygant N, Du J, Yan Z, et al. Role of DCLK1 in oncogenic signaling (review). Int J Oncol. 2022;61:137.","journal-title":"Int J Oncol"},{"key":"5960_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.canlet.2022.01.030","volume":"531","author":"R Yan","year":"2022","unstructured":"Yan R, Fan X, Xiao Z, Liu H, Huang X, Liu J, et al. Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt\/\u03b2-Catenin activity and cancer stemness. Cancer Lett. 2022;531:83\u201397.","journal-title":"Cancer Lett"},{"key":"5960_CR53","doi-asserted-by":"publisher","first-page":"650403","DOI":"10.3389\/fphar.2021.650403","volume":"12","author":"H Honjo","year":"2021","unstructured":"Honjo H, Watanabe T, Kamata K, Minaga K, Kudo M. RIPK2 as a new therapeutic target in inflammatory bowel diseases. Front Pharm. 2021;12:650403.","journal-title":"Front Pharm"},{"key":"5960_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06451-3","volume":"9","author":"E Pellegrini","year":"2018","unstructured":"Pellegrini E, Desfosses A, Wallmann A, Schulze WM, Rehbein K, Mas P, et al. RIP2 filament formation is required for NOD2 dependent NF-\u03baB signalling. Nat Commun. 2018;9:4043.","journal-title":"Nat Commun"},{"key":"5960_CR55","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/intimm\/dxz045","volume":"31","author":"T Watanabe","year":"2019","unstructured":"Watanabe T, Minaga K, Kamata K, Sakurai T, Komeda Y, Nagai T, et al. RICK\/RIP2 is a NOD2-independent nodal point of gut inflammation. Int Immunol. 2019;31:669\u201383.","journal-title":"Int Immunol"},{"key":"5960_CR56","doi-asserted-by":"publisher","first-page":"a035154","DOI":"10.1101\/cshperspect.a035154","volume":"11","author":"RD Burgoyne","year":"2019","unstructured":"Burgoyne RD, Helassa N, McCue HV, Haynes LP. Calcium sensors in neuronal function and dysfunction. Cold Spring Harb Perspect Biol. 2019;11:a035154.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5960_CR57","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/CIRCULATIONAHA.118.039357","volume":"140","author":"G Agha","year":"2019","unstructured":"Agha G, Mendelson MM, Ward-Caviness CK, Joehanes R, Huan T, Gondalia R, et al. Blood leukocyte DNA methylation predicts risk of future myocardial infarction and coronary heart disease. Circulation. 2019;140:645\u201357.","journal-title":"Circulation"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05960-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05960-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05960-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T07:03:48Z","timestamp":1689231828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-023-05960-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["5960"],"URL":"https:\/\/doi.org\/10.1038\/s41419-023-05960-4","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"assertion":[{"value":"7 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were reviewed and approved by the Animal Policy and Welfare Committee at Wenzhou Medical University (No. wydw2018-0224).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"419"}}